Michael Zhang's Form 3 Filing for Anbio Biotechnology Director Position

This is a Form 3 filing by Michael Zhang (CIK: 0002140420) reporting his initial statement of beneficial ownership in Anbio Biotechnology (CIK: 0001982708, ticker: NNNN). The filing, dated June 12, 2026, indicates that Zhang has become a director of the company as of March 18, 2026. The filing shows that Zhang currently owns no securities in the company, as indicated by the "noSecuritiesOwned" flag set to "1." Zhang is based in Frankfurt, Germany, and the filing was signed electronically on June 12, 2026. Form 3 filings are required when individuals become officers, directors, or beneficial owners of more than 10% of a company's registered class of securities, even if they don't currently own any shares.